Like other politicians, from all sides, he urges the government to block this operation.
“The President of the Republic is taking care today of ensuring that Emily in Paris remains in France. I would prefer that he takes care of ensuring that Doliprane remains French”shouts Olivier Faure this Sunday.
.@faureolivier : “The President is taking care today of ensuring that Emily in Paris remains in France, I would prefer that he takes care of ensuring that Doliprane remains French. There is a law which allows, on the subjects sanitary facilities, to block a sale.” #QuestionsPol pic.twitter.com/ODVwvCmOQ9
— France Inter (@franceinter) https://twitter.com/franceinter/status/1845407578525716766?ref_src=twsrc%5Etfw
Guest of the show “Political Questions” on France Inter, France Info and Le Monde, the deputy for Seine-et-Marne and first secretary of the PS tackles Emmanuel Macron who said on Wednesday he wanted to fight so that the Netflix phenomenon series does not leave not by Paris for Rome. “We will fight hard. And we will ask them to stay in Paris! “Emily in Paris” in Rome makes no sense,” said the head of state.
Best-selling drug in France
The next day, Les Echos and Le Monde revealed that negotiations were underway between Sanofi and Clayton Dubilier & Rice (CD&R) with a view to selling Doliprane, the best-selling drug in France, to the American investment fund.
Sanofi confirmed on Friday these negotiations with CD & R to sell it a 50% controlling stake in Opella, its consumer health division.
In a press release, Antoine Armand, Minister of the Economy, Finance and Industry, and Marc Ferracci, Minister Delegate in charge of Industry, recalled “that the government wishes to preserve and develop these economically efficient sites” in France. .
“We have indicated that a certain number of economic commitments will be required from Sanofi and the future buyer CD & R,” added the ministers.
